Literature DB >> 10458516

Nociceptin/orphanin FQ increases blood pressure and heart rate via sympathetic activation in sheep.

M L Arndt1, D Wu, Y Soong, H H Szeto.   

Abstract

This study was undertaken to examine the cardiovascular effects of nociceptin/Orphanin FQ (OFQ). Nociceptin/OFQ (10-300 nmol/kg, IV) stimulates an increase in mean blood pressure (MBP) and heart rate (HR) in chronically catheterized sheep. Pretreatment with phenoxybenzamine (5 mg/kg) attenuated the pressor response, consistent with sympathetically mediated vasoconstriction. Furthermore, the lack of a reflex bradycardia suggests either blunting of the baroreflex by nociceptin/OFQ or direct beta-adrenergic activation. The bradycardic response to norepinephrine (0.6 microg/kg, IV) remained intact after nociceptin/OFQ administration, demonstrating that nociceptin/OFQ does not blunt the baroreflex. Additionally, the increase in HR was completely reversed by pretreatment with propranolol. These data suggest that nociceptin/OFQ plays a role in cardiovascular regulation via sympathetic activation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10458516     DOI: 10.1016/s0196-9781(99)00027-3

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  5 in total

Review 1.  Pharmacology of nociceptin and its receptor: a novel therapeutic target.

Authors:  G Calo'; R Guerrini; A Rizzi; S Salvadori; D Regoli
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

2.  Stimulation of sensory neuropeptide release by nociceptin/orphanin FQ leads to hyperaemia in acutely inflamed rat knees.

Authors:  Chunfen Zhang; Jason J McDougall
Journal:  Br J Pharmacol       Date:  2006-06-19       Impact factor: 8.739

3.  Brain opioid and nociceptin receptors are involved in regulation of bombesin-induced activation of central sympatho-adrenomedullary outflow in the rat.

Authors:  Toshio Yawata; Youichirou Higashi; Takahiro Shimizu; Shogo Shimizu; Kumiko Nakamura; Keisuke Taniuchi; Tetsuya Ueba; Motoaki Saito
Journal:  Mol Cell Biochem       Date:  2015-10-01       Impact factor: 3.396

Review 4.  Prospects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor Agonists.

Authors:  Leonid N Maslov; Igor Khaliulin; Peter R Oeltgen; Natalia V Naryzhnaya; Jian-Ming Pei; Stephen A Brown; Yury B Lishmanov; James M Downey
Journal:  Med Res Rev       Date:  2016-05-16       Impact factor: 12.944

5.  Multi-Omics Characterization of a Human Stem Cell-Based Model of Cardiac Hypertrophy.

Authors:  Markus Johansson; Benjamin Ulfenborg; Christian X Andersson; Sepideh Heydarkhan-Hagvall; Anders Jeppsson; Peter Sartipy; Jane Synnergren
Journal:  Life (Basel)       Date:  2022-02-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.